Molecular Sensing and Point-of-care Technologies
The research focuses on developing advanced biomolecular sensors and devices for rapid detection of gases, bodily fluids, or other samples at the point of care.
The goal is to improve the speed and accuracy of medical diagnostics, especially in urgent scenarios, to aid in faster decision-making.
Projects
The 4PC project aims to create a model which predicts the most cost-effective production method for photonic point-of-care cartridges.
Developing a portable micro-/nanoparticle sizer based on nano-electrochemical sensing.
Both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) in intensive care (ICU) patients are strongly associated with increased morbidity and mortality. Accurate and timely measurement of glucose levels in this population is therefore crucial. Continuous glucose monitoring (CGM) appears promising for this purpose, but it is not yet used in the ICU due to insufficient knowledge about its reliability in the ICU population. The aim of this pilot study is to investigate (1) the discrepancy between CGM and point-of-care measurements in ICU patients, and (2) whether this discrepancy is consistent across all ICU patient groups/characteristics.
DIAgnosis and MONitoring of Diabetes type 2.
Glucose sensing with optical fibers.
The OBSeRVeD project aims to develop a sensor system for early detection of poultry health issues using volatile organic compounds, enhancing disease control, animal welfare, and public health.
Highly multiplexed photonics integrated circuits (PIC) sensors for the rapid diagnostics of sepsis.